ABUS
Arbutus Biopharma Corporation
NASDAQ · Healthcare · Biotechnology · US
$5.15
+0.59%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- 6.94x
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 255.06x
Trailing multiples
Trailing twelve months
- P/E TTM
- 6.51x
- PEG TTM
- —
- Price / book
- 3.94x
- Price / sales
- 5.61x
- Price / cash flow
- -41.43x
Enterprise value
- Enterprise value
- $931.2M
- EV / sales
- 5.12x
- EV / EBITDA
- 6.08x
- EV / EBIT
- 6.33x
- Market cap
- $1.0B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026